Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-26 @ 7:54 PM
Study NCT ID:
NCT03151161
Status:
UNKNOWN
Last Update Posted:
2018-06-07
First Post:
2017-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2018-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-05
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-11
First Submit QC Date:
None
Study First Post Date:
2017-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-05
Last Update Post Date:
2018-06-07
Last Update Post Date Type:
ACTUAL